Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.
Press releases published on April 1, 2025
Hesai Group Files Its Annual Report on Form 20-F
GlobeNewswire
·
April 1, 2025
SHANGHAI, China, April 01, 2025 (GLOBE NEWSWIRE) -- Hesai Group (“Hesai” or the “Company”) (NASDAQ: HSAI), the global leader in three-dimensional light detection and ranging (lidar) solutions, today announced that it filed its annual report on Form 20-F …
NowVertical Reports Record 2024 Financial Results
GlobeNewswire
·
April 1, 2025
Company Hosting Investor Webinar on April 2, 2025, at 10:00 AM EST Q4 2024 revenue was $10.9 million, up 94% Y/Y excluding recent divestitures On a reported basis, Q4 2024 revenue increased 8% Y/Y Q4 2024 Net Income was $0.6 million, up 115% Y/Y excluding …
UPDATE – Reborn Coffee Provides Fourth Quarter and Full Year 2024 Corporate Update and Financial Results
GlobeNewswire
·
April 1, 2025
FY 2024 Annual Revenue Growth to $5.9 Million and Strong 31% Increase in Q4 Revenue to $1.8 Million Approved as U.S. Franchisor and Signed Commitments for 33 New Locations Through a Combination of Area Development and Franchise Agreements BREA, Calif., …
ROSEN, A TOP RANKED LAW FIRM, Encourages Semtech Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – SMTC
GlobeNewswire
·
April 1, 2025
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Semtech Corporation (NASDAQ: SMTC) between August 27, 2024 and February 7, 2025, both dates inclusive (the “Class …
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 1, 2025
SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
Business First Bancshares, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call
GlobeNewswire
·
April 1, 2025
BATON ROUGE, La., April 01, 2025 (GLOBE NEWSWIRE) -- Business First Bancshares, Inc. (Nasdaq: BFST), the parent company of b1BANK, is scheduled to release first quarter 2025 earnings after market close on Thursday, April 24, 2025. Executive management will …
SMTC Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Semtech Corporation (SMTC)
GlobeNewswire
·
April 1, 2025
RADNOR, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer …
Colliers Announces Voting Results
GlobeNewswire
·
April 1, 2025
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Colliers International Group Inc. (TSX: CIGI; NASDAQ: CIGI) (“Colliers” or the “Company”) today announced that at its annual meeting of shareholders held virtually on April 1, 2025, the ten director nominees …
Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis
GlobeNewswire
·
April 1, 2025
Target enrollment exceeded with 1009 patients randomized in the main cohort and 410 patients in the exploratory cohort Topline results from NATiV3 projected in the second half of 2026 and, if positive, expected to be the basis for submission for regulatory …
Inventiva annonce la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et de fibrose avancée
GlobeNewswire
·
April 1, 2025
Objectifs de recrutement dépassés avec 1.009 patients randomisés dans la cohorte principale et 411 dans la cohorte exploratoire Principaux résultats de NATiV3 attendus au deuxième semestre 2026 et, si positifs, ils supporteront les demandes règlementaires …
Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire
·
April 1, 2025
SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that the Compensation and Human …
Pennant Expands Portfolio with Acquisition of Senior Living Community in Arizona
GlobeNewswire
·
April 1, 2025
EAGLE, Idaho, April 01, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of the real estate and …
Venus Concept Announces $11 million Debt-to-Equity Exchange Transaction
GlobeNewswire
·
April 1, 2025
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on March 31, 2025, the Company exchanged $11.0 million of its subordinated …
Safe & Green Holdings Reports Year-End 2024 Results
GlobeNewswire
·
April 1, 2025
MIAMI, April 01, 2025 (GLOBE NEWSWIRE) -- Safe …
HCW Biologics Announces 1-for-40 Reverse Stock Split
GlobeNewswire
·
April 1, 2025
MIRAMAR, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by …
Jeffs’ Brands Reports Record $13.6 Million Revenue for 2024
GlobeNewswire
·
April 1, 2025
Tel Aviv, Israel, April 01, 2025 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, today announced the filing of its Annual Report on Form …
O’Reilly Automotive, Inc. Announces Dates for Its First Quarter 2025 Earnings Release and Conference Call
GlobeNewswire
·
April 1, 2025
Earnings Release Date – Wednesday, April 23, 2025, after 3:30 p.m. Central Time Conference Call Date – Thursday, April 24, 2025, at 10:00 a.m. Central Time SPRINGFIELD, Mo., April 01, 2025 (GLOBE NEWSWIRE) -- O’Reilly Automotive, Inc. (the “Company” or “O’ …
Castle Biosciences to Present New Data at EADO Supporting the Clinical Value of the DecisionDx®-Melanoma Test in Guiding Risk-Aligned Management of Patients with Melanoma
GlobeNewswire
·
April 1, 2025
Two posters will share data on the significant risk stratification provided by DecisionDx-Melanoma in a real-world cohort of patients with stage IIB-IIC cutaneous melanoma (CM) to help guide adjuvant therapy, and the role of the test in prompting use of …
Antelope Enterprise Announces One-for-40 Reverse Stock Split
GlobeNewswire
·
April 1, 2025
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Antelope Enterprise Holdings Limited (NASDAQ Capital Market: AEHL) (“Antelope Enterprise”, “AEHL” or the “Company”), the majority interest owner of Kylin Cloud, a livestreaming e-commerce business in China, …
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 1, 2025
FLORHAM PARK, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in …